Literature DB >> 10676733

Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs.

C S Yang1, C H Lin, S H Chang, H C Hsu.   

Abstract

Rapidly progressive fibrosing interstitial nephritis after a slimming regimen containing aristolochic acid has been identified as Chinese herbs nephropathy (CHNP). From 1995 to 1998, we observed 12 Chinese people from different areas of Taiwan who underwent renal biopsy for unexplained renal failure. Medical history gave no clue to the causes of impaired renal function except for the ingestion of traditional Chinese herbs. Although these patients ingested herbal drugs from various sources for different purposes, their renal biopsy samples showed amazingly similar histological findings, with extensive hypocellular interstitial fibrosis and atrophy and loss of tubules in all cases. Glomeruli were apparently intact. They also had similar clinical features, such as normal or mildly elevated blood pressure, early and severe anemia, low-grade proteinuria, glycosuria, and insignificant urinary sediments. Renal function deteriorated rapidly in most patients despite discontinuation of the herbal medicines. Seven patients underwent dialysis, and the remainder experienced slowly progressive renal failure. Bladder carcinoma was found in one patient. Morphologically and clinically, the nephropathy in our patients was similar to CHNP, reported in Belgium. Because of the complexity and unknown types of herbs used in different clinical situations, unidentified phytotoxins other than aristolochic acid might be responsible for this unique disease entity. We conclude that the relation of this nephropathy to the consumption of Chinese herbs is striking. Using uncontrolled herbal remedies carries a high risk for developing interstitial renal fibrosis and urothelial malignancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10676733     DOI: 10.1016/s0272-6386(00)70343-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  28 in total

Review 1.  Nephrology: 3. Safe drug prescribing for patients with renal insufficiency.

Authors:  Joanne Kappel; Piera Calissi
Journal:  CMAJ       Date:  2002-02-19       Impact factor: 8.262

2.  Isogenic mesenchymal stem cells transplantation improves a rat model of chronic aristolochic acid nephropathy via upregulation of hepatic growth factor and downregulation of transforming growth factor β1.

Authors:  Wei Li; Hong Jiang; Jiang-Min Feng
Journal:  Mol Cell Biochem       Date:  2012-06-04       Impact factor: 3.396

3.  Peripheral blood-derived endothelial progenitor cell therapy prevented deterioration of chronic kidney disease in rats.

Authors:  Tien-Hung Huang; Yen-Ta Chen; Pei-Hsun Sung; Hsin-Ju Chiang; Yung-Lung Chen; Han-Tan Chai; Sheng-Ying Chung; Tzu-Hsien Tsai; Chih-Chao Yang; Chih-Hung Chen; Yi-Ling Chen; Hsueh-Wen Chang; Cheuk-Kwan Sun; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

4.  [Evaluation of renal oxygenation in rats with acute aristolochic acid nephropathy using blood oxygenation level-dependent magnetic resonance imaging].

Authors:  Guixiang Yang; Yingjie Mei; Jian Lü; Quan Tao; Yanqiu Feng; Yikai Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-05-30

Review 5.  Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.

Authors:  Randy L Luciano; Mark A Perazella
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

6.  Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.

Authors:  Ming-Nan Lai; Shuo-Meng Wang; Pau-Chung Chen; Ya-Yin Chen; Jung-Der Wang
Journal:  J Natl Cancer Inst       Date:  2009-12-21       Impact factor: 13.506

Review 7.  Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.

Authors:  Jean-Pierre Cosyns
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.

Authors:  Li Zhou; Ping Fu; Xiao R Huang; Fei Liu; Kar Neng Lai; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 10.121

9.  Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs.

Authors:  Yin-Tai Hong; Lin-Shien Fu; Lin-Huei Chung; Shien-Chung Hung; Yi-Ting Huang; Chin-Shiang Chi
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

10.  Factors associated with CKD in the elderly and nonelderly population.

Authors:  Ming-Yen Lin; Yi-Wen Chiu; Chien-Hung Lee; Hui-Yen Yu; Hung-Chun Chen; Ming-Tsang Wu; Shang-Jyh Hwang
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-18       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.